IL33 and colorectal cancer: Furthermore, inhibiting the IL-33/ST2 pathway in a mouse model of AOM/DSS-induced colorectal cancer can reduce the proliferation and migration of CD4+Foxp3+ST2+ Treg cells by downregulating integrins and chemokine receptor expression.